EU/3/18/2042

Table of contents

About

On 31 July 2018, orphan designation (EU/3/18/2042) was granted by the European Commission to MeiraGTx UK II Limited, United Kingdom, for adenovirus associated viral vector serotype 2/8 containing the human CNGA3 gene for the treatment of achromatopsia.

Key facts

Active substance
Adenovirus associated viral vector serotype 2/8 containing the human CNGA3 gene
Disease / condition
Treatment of achromatopsia
Date of decision
31/07/2018
Outcome
Positive
Orphan decision number
EU/3/18/2042

Sponsor's contact details

MeiraGTx UK II Limited
92 Britannia Walk
London N1 7NQ
United Kingdom
Tel. +44 (0)20 3866 4320
E-mail: info@meiragtx.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;

How useful was this page?

Add your rating